Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Biotechnol Rep (Amst) ; 35: e00742, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-35677324

RESUMEN

Fungi is a notable asset for drug discovery and production of pharmaceuticals; however, slow growth and poor product yields have hindered industrial utilization. Here, the mycelial biomass of Xylaria sp. BCC 1067 was examined in parallel with the assessment of antimicrobial properties by using media-type selection. To enhance both mycelial content and antifungal activity, the media replacement approach was successfully applied to stimulate fungal growth and successively switched to poorer malt-peptone extract media for metabolite production. This simple optimization reduced fungal cultivation time by 7 days and yielded 4-fold increased mycelial mass (32.59 g/L), with approximately 3-fold increased antifungal activity against the model yeast Saccharomyces cerevisiae strain. A high level of ß-glucan (115.84 mg/g of cell dry weight) and additive antibacterial effect against Propionibacterium acnes were also reported. This simple strategy of culture media optimization allows for investigation of novel and rich source of health-promoting substances for effective microbial utilization.

2.
Future Microbiol ; 12: 417-440, 2017 04.
Artículo en Inglés | MEDLINE | ID: mdl-28361556

RESUMEN

AIM: To investigate antifungal potential of Xylaria sp. BIOTEC culture collection (BCC) 1067 extract against the model yeast Saccharomyces cerevisiae. MATERIALS & METHODS: Antifungal property of extract, reactive oxygen species levels and cell survival were determined, using selected deletion strains. RESULTS: Extract showed promising antifungal effect with minimal inhibitory concentration100 and minimal fungicidal concentration of 500 and 1000 mg/l, respectively. Strong synergy was observed with fractional inhibitory concentration index value of 0.185 for the combination of 60.0 and 0.5 mg/l of extract and ketoconazole, respectively. Extract-induced intracellular reactive oxygen species levels in some oxidant-prone strains and mediated plasma membrane rupture. Antioxidant regulator Yap1, efflux transporter Pdr5 and ascorbate were pivotal to protect S. cerevisiae from extract cytotoxicity. CONCLUSION: Xylaria sp. BCC 1067 extract is a potentially valuable source of novel antifungals.


Asunto(s)
Antifúngicos/farmacología , Productos Biológicos/farmacología , Mezclas Complejas/farmacología , Farmacorresistencia Fúngica Múltiple , Estrés Oxidativo , Saccharomyces cerevisiae/efectos de los fármacos , Xylariales/química , Antifúngicos/aislamiento & purificación , Productos Biológicos/aislamiento & purificación , Mezclas Complejas/aislamiento & purificación , Viabilidad Microbiana/efectos de los fármacos , Especies Reactivas de Oxígeno/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA